Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease

• Alessia Lodi ,

  Contributed equally to this work with: Alessia Lodi, Stefano Tiziani

  * E-mail: alessia@austin.utexas.edu (AL); m.t.drayson@bham.ac.uk (MTD)

  Affiliations School of Cancer Sciences, The University of Birmingham, Birmingham, United Kingdom, Department of Nutritional Sciences, The University of Texas at Austin, Austin, Texas, United States of America

  ⨯
• Stefano Tiziani ,

  Contributed equally to this work with: Alessia Lodi, Stefano Tiziani

  Affiliations School of Cancer Sciences, The University of Birmingham, Birmingham, United Kingdom, Department of Nutritional Sciences, The University of Texas at Austin, Austin, Texas, United States of America, Dell Pediatric Research Institute, The University of Texas at Austin, Austin, Texas, United States of America

  ⨯
• Farhat L. Khanim,

  Affiliation School of Biosciences, The University of Birmingham, Birmingham, United Kingdom

  ⨯
• Ulrich L. Günther,

  Affiliation School of Cancer Sciences, The University of Birmingham, Birmingham, United Kingdom

  ⨯
• Mark R. Viant,

  Affiliation School of Biosciences, The University of Birmingham, Birmingham, United Kingdom

  ⨯
• Gareth J. Morgan,

  Affiliation Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, United Kingdom

  ⨯
• Christopher M. Bunce,

  Affiliation School of Biosciences, The University of Birmingham, Birmingham, United Kingdom

  ⨯
• Mark T. Drayson

  * E-mail: alessia@austin.utexas.edu (AL); m.t.drayson@bham.ac.uk (MTD)

  Affiliation School of Immunity and Infection, The University of Birmingham, Birmingham, United Kingdom

  ⨯